Octreotide Acetate (Sandoz Inc)


Welcome to the PulseAid listing for the Octreotide Acetate drug offered from Sandoz Inc. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Octreotide Acetate
SUBSTANCE NAME: OCTREOTIDE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1988-10-21
END MARKETING DATE: 0000-00-00


Octreotide Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOctreotide Acetate from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1000(ug/mL)
START MARKETING DATE: 1988-10-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3164_b02b276f-9007-4ec7-8bcd-40f14213d7f5
PRODUCT NDC: 0781-3164
APPLICATION NUMBER: NDA019667

Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCOctreotide
Mylan Institutional LLCOctreotide Acetate
Novartis Pharmaceuticals CorporationSandostatin
Sagent PharmaceuticalsOctreotide Acetate
Sandoz IncOctreotide Acetate
Teva Parenteral Medicines, Inc.Octreotide Acetate
West-Ward Pharmaceuticals Corp.Octreotide Acetate
Wockhardt LimitedOctreotide acetate
Wockhardt USA LLC.Octreotide acetate